Cargando…
A novel Bayesian adaptive design incorporating both primary and secondary endpoints for randomized IIB chemoprevention study of women at increased risk for breast cancer
BACKGROUND: Our randomized controlled clinical trial will explore the potential of bazedoxifene plus conjugated estrogen to modulate breast tissue-based risk biomarkers as a surrogate for breast cancer risk reduction. This paper investigates the statistical design features of the trial and the ratio...
Autores principales: | Gajewski, Byron J., Kimler, Bruce F., Koestler, Devin C., Mudaranthakam, Dinesh Pal, Young, Kate, Fabian, Carol J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721008/ https://www.ncbi.nlm.nih.gov/pubmed/36471449 http://dx.doi.org/10.1186/s13063-022-06930-5 |
Ejemplares similares
-
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
por: Brown, Alexandra R., et al.
Publicado: (2016) -
Relevant Word Order Vectorization for Improved Natural Language Processing in Electronic Health Records
por: Thompson, Jeffrey, et al.
Publicado: (2019) -
Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients
por: Gao, Guangyi, et al.
Publicado: (2022) -
A Curated Cancer Clinical Outcomes Database (C3OD) for accelerating patient recruitment in cancer clinical trials
por: Mudaranthakam, Dinesh Pal, et al.
Publicado: (2018) -
Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated Trials
por: Mudaranthakam, Dinesh Pal, et al.
Publicado: (2020)